Posts in Category: Cancer Research

Mikhail Blagosklonny Promotes The Use Of The Rapamycin As A Suitable Treatment For Cancer

Success in the area of medicine requires excellent input from a personal approach, and that is precisely what Mikhail V. Blagosklonny has managed to achieve. As one of the outstanding medical researchers, Mikhail V. Blagosklonny works hard on a daily basis to understand how cancer and old age develop in the human body. It is a puzzle that has faced scientists and doctors for centuries, and in most cases, having cancer is compared to a death sentence.However, Mikhail V. Blagosklonny has worked hard to ensure that in an area where hope was lost, success is obtained. Taking advantage of technological progression in different industries including that of medicine, Mikhail V. Blagosklonny has managed to rewrite history, and this has made him become respected in his profession. Mikhail V. Blagosklonny worked hard to try and understand aging and how it affects the human body.

He tries to answer why people get old and they end up being exposed to other diseases. Previously, it was known that people grow old due to the decline of cell regeneration, and the damage that is extended to molecules within the structure of organisms. More importantly, scientists believed that with proper medication and nutrition, aging could somehow be prevented. As time progressed, a theory was developed and it came to be known as the hyperfunction theory.The argument stated that aging is a merely the progression of the normal growing process. The signaling pathways facilitate old age within organisms. Many electrical pathways exist within the structure of an organism such as the Target of Rapamycin (TOR). Scientists such as Mikhail V. Blagosklonny have embraced the idea that rapamycin can be used to prevent aging. Consumption of the correct amount of rapamycin can extensively reduce the rate of aging, and even help to configure the body so that the lifespan of an organism becomes extended.

Different versions of rapamycin have been produced for use in the general society. Some versions of rapamycin are produced as supplements that can be consumed without any strict prescription. One common type of rapamycin is Evirolimus (RAD001). The medication tackles fast aging process, and it rejuvenates the health of an older adult. Scientists such as Mikhail V. Blagosklonny have played an enormous role in ensuring that such success is cemented in the area of medicine.Actually, in most of Mikhail V. Blagosklonny’s publications on Oncotarget, he emphasizes the importance of using rapamycin as a suitable treatment for cancer. Mikhail V. Blagosklonny is the chief editor of the website, and he believes that the correct dosage of rapamycin allows the human body to become age tolerant. However, he states that the best results from rapamycin can be obtained when it is combined with other medical processes designed to tackle the aging process.As a well-renowned scientist, Mikhail V. Blagosklonny advises other gerontologists to pull away from the study of molecular damage and the effects of free radicals as the causative agents of age progression. Adopting the hyperfunction theory is seen as the key to achieving success in the field of medicine.

Clay Siegall loves working with Seattle Genetics

Clay Siegall is one of the most influential names in the genetics industry. He strongly believes that genetics can help open doors for doctors around the world. He thinks that genetic therapy can cure cancer and several other diseases. Clay is extremely insightful and he is well-respected throughout the biotechnology field.

Siegall founded Seattle Genetics in the late nineties. When he started the company his goal was to develop antibody-based treatments. His leadership has allowed the company to develop several antibody-based therapies to meet the needs of cancer patients. These therapies have been extremely effective and have led to a greater quality of life for cancer patients everywhere. Seattle Genetics launched their first product, ADCETRIS, in 2011. The company now has a large pipeline of therapies set to come out in the coming years. Siegall believes that the company should work closely with other biotechnology companies to produce the best possible products. He wants to best serve patients around the world, and he knows that collaboration is the key to properly serving patients throughout the world.

Siegall loves working with other biotechnology companies. Recently, Siegall was appointed to the board of directors for Mirna Therapeutics. Mirna is a biotechnology company based in Austin. They primarily focus on developing microRNA therapies. Their therapies are extremely impactful, but they want as much insight as possible. Clay Siegall will bring years of medical experience to the company, and he hopes to lead them to new heights.

Clay also serves on the Ultragenyx board. Ultragenyx is an extremely powerful pharmaceutical company. They added Siegall to their board two year ago, and they are extremely happy to have his insight on their board. Clay has years of experience working with biotechnology, and he wants to help Ultragenyx develop new technologies that will help patients. His collaborative personality has been a major asset for the company.

Genetics can cure many different diseases, and Seattle Genetics intends to play a huge role in these cures. They have unveiled several successful products and they intend to keep revealing products for years to come. Clay Siegall is a brilliant leader and he will work with Seattle Genetics for years to come.

Learn More:

http://www.ultragenyx.com/about/board/siegall/

http://www.pegsummit.com/uploadedFiles/PEGS/Agenda/15/PEGS-Interview-Siegall.pdf